UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 11, 2008
SUNESIS PHARMACEUTICALS, INC. |
| (Exact Name of Registrant as Specified in its Charter) |
Delaware | 000-51531 | 94-3295878 |
| (State or Other Jurisdiction | (Commission | (IRS Employer |
| of Incorporation) | File Number) | Identification No.) |
341 Oyster Point Boulevard South San Francisco, California | 94080 |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (650) 266-3500
Not Applicable |
| (Former Name or Former Address, if Changed Since Last Report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations & Financial Condition.
On March 11, 2008, Sunesis Pharmaceuticals, Inc. issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2007. A copy of the press release is attached hereto as Exhibit 99.1
Item 9.01. Financial Statements and Exhibits.
| (d) | Exhibits |
Exhibit No. | Description |
| 99.1 | Press release issued by Sunesis Pharmaceuticals, Inc., dated March 11, 2008. |
* * * * * * * * *
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SUNESIS PHARMACEUTICALS, INC. | ||
| Date: March 11, 2008 | ||
| By: | /s/ ERIC H. BJERKHOLT | |
| Eric H. Bjerkholt | ||
| Senior Vice President, Corporate Development and Finance | ||
EXHIBIT INDEX
Exhibit No. | Description |
| 99.1 | Press release issued by Sunesis Pharmaceuticals, Inc., dated March 11, 2008. |